EP Patent

EP0576230B1 — 2'-deoxy-2', 2'-difluoro(4-substituted pyrimidine) nucleosides having antiviral and anti-cancer activity and intermediates

Assigned to Eli Lilly and Co · Expires 1996-04-24 · 30y expired

What this patent protects

2-Deoxy-2,2-Difluoro (4-Substituted) Pyrimidine Nucleosides Having Anti-Cancer and Anti-Viral Activity and Intermediates.

USPTO Abstract

2-Deoxy-2,2-Difluoro (4-Substituted) Pyrimidine Nucleosides Having Anti-Cancer and Anti-Viral Activity and Intermediates.

Drugs covered by this patent

Patent Metadata

Patent number
EP0576230B1
Jurisdiction
EP
Classification
—
Expires
1996-04-24
Drug substance claim
No
Drug product claim
No
Assignee
Eli Lilly and Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.